Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | APAF1 | O14727 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | PON1 | P27169 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17076982 | 0.98 | MEN1 (0.46) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| Iodide SCHEMBL6651538 | 0.96 | MEN1 (0.45) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| Acetic Acid SCHEMBL17076865 | 0.91 | SMN1; SMN2 (0.41) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL16674008 | 0.88 | SMN1; SMN2 (0.53) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| 1-Methylimidazole SCHEMBL15575238 | 0.85 | NFKB1 (0.41) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL6293502 | 0.84 | MEN1 (0.73) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL12936199 | 0.83 | SMN1; SMN2 (0.58) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL899258 | 0.83 | SMN1; SMN2 (0.53) | MEN1KMT2ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL718979 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL16713772 | 0.81 | SMN1; SMN2 (0.56) | MEN1KMT2ASMN1; SMN2MAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140174320-A1 | IONIC LIQUID AND VISCOSE COMPOSITION | TAIWAN TEXTILE RESEARCH INSTITUTE (TW) | 2014-06-26 | — | — | US | disclosed |
| EP-1867667-B1 | Method for manufacturing stabilized polyacetal resin | POLYPLASTICS CO (JP) | 2012-10-31 | — | — | EP | disclosed |
| US-20080271381-A1 | Method for manufacturing stabilized polyacetal resin, stabilized polyacetal resin, stabilized polyacetal resin composition, and molded article of stabilized polyacetal resin | POLYPLASTICS CO., LTD (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1867667-A1 | Method for manufacturing stabilized polyacetal resin, stabilized polyacetal resin, stabilized polyacetal resin composition, and molded article of stabilized polyacetal resin | Polyplastics Co., Ltd. (JP) | 2007-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140174320-A1 | IONIC LIQUID AND VISCOSE COMPOSITION | COL2A1, COL1A1, CD44 | MEN1 4293/4885KMT2A 3195/4885SMN1; SMN2 3103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.